Role of reactive nitrogen species generated via inducible nitric oxide synthase in vesicant-induced lung injury, inflammation and altered lung functioning

Toxicology and Applied Pharmacology

Volumn 261, Issue 1, 2012, Pages 22-30

  Sunil, Vasanthi R ^a   Shen, Jianliang ^a   Patel Vayas, Kinal ^a   Gow, Andrew J ^a   Laskin, Jeffrey D ^b   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

CEES; COX 2; INOS; Lcn2; Lung function; MCP 1; RNS; Ym1

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MUSTARD GAS; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REACTIVE NITROGEN SPECIES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; LUNG RESISTANCE; LUNG TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PROTEIN CONTENT; PROTEIN EXPRESSION; TISSUE REPAIR; UPREGULATION; WILD TYPE;

ACUTE-PHASE PROTEINS; ANIMALS; CHEMICAL WARFARE AGENTS; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOCALINS; LUNG; LUNG INJURY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSTARD GAS; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEINS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84860507140     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.03.004     Document Type: Article

References (51)

1. Allon N., Chapman S., Shalem Y., Brandeis R., Weissman B.A., Amir A. Lipopolysaccharide induced protection against sulfur mustard cytotoxicity in RAW264.7 cells through generation of TNF-alpha. J. Toxicol. Sci. 2010, 35:345-355.
2. Anderson D.R., Byers S.L., Vesely K.R. Treatment of sulfur mustard (HD)-induced lung injury. J. Appl. Toxicol. 2000, 20(Suppl. 1):S129-S132.
3. Bahmani P., Halabian R., Rouhbakhsh M., Roushandeh A.M., Masroori N., Ebrahimi M., Samadikuchaksaraei A., Shokrgozar M.A., Roudkenar M.H. Neutrophil gelatinase-associated lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2. Cell Stress Chaperones 2010, 15:395-403.
4. Balali-Mood M., Afshari R., Zojaji R., Kahrom H., Kamrani M., Attaran D., Mousavi S.R., Zare G.A. Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans. Hum. Exp. Toxicol. 2011, 30:1141-1149.
5. Balamayooran G., Batra S., Balamayooran T., Cai S., Jeyaseelan S. Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect. Immun. 2011, 79:2567-2577.
6. Bates J.H., Lauzon A.M. Parenchymal tethering, airway wall stiffness, and the dynamics of bronchoconstriction. J. Appl. Physiol. 2007, 102:1912-1920.
7. Bhalla D.K. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications. J. Toxicol. Environ. Health B Crit. Rev. 1999, 2:31-86.
8. Borkham-Kamphorst E., Drews F., Weiskirchen R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation. Liver Int. 2011, 31:656-665.
9. Chapman R.W., Phillips J.E., Hipkin R.W., Curran A.K., Lundell D., Fine J.S. CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol. Ther. 2009, 121:55-68.
10. Chen H.I. From neurogenic pulmonary edema to fat embolism syndrome: a brief review of experimental and clinical investigations of acute lung injury and acute respiratory distress syndrome. Chin. J. Physiol. 2009, 52:339-344.
11. Chung K.F. Inflammatory mediators in chronic obstructive pulmonary disease. Curr. Drug Targets Inflamm. Allergy 2005, 4:619-625.
12. Conti P., DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 2001, 22:133-137.
13. Das S.K., Mukherjee S., Smith M.G., Chatterjee D. Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue. J. Biochem. Mol. Toxicol. 2003, 17:177-184.
14. Dittrich A.M., Krokowski M., Meyer H.A., Quarcoo D., Avagyan A., Ahrens B., Kube S.M., Witzenrath M., Loddenkemper C., Cowland J.B., Hamelmann E. Lipocalin2 protects against airway inflammation and hyperresponsiveness in a murine model of allergic airway disease. Clin. Exp. Allergy 2010, 40:1689-1700.
15. Ebrahimi M., Roudkenar M.H., Imani Fooladi A.A., Halabian R., Ghanei M., Kondo H., Nourani M.R. Discrepancy between mRNA and protein expression of neutrophil gelatinase-associated lipocalin in bronchial epithelium induced by sulfur mustard. J. Biomed. Biotechnol. 2010, 2010:823131.
16. Elsayed N.M., Omaye S.T. Biochemical changes in mouse lung after subcutaneous injection of the sulfur mustard 2-chloroethyl 4-chlorobutyl sulfide. Toxicology 2004, 199:195-206.
17. Emad A., Emad V. Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 2007, 240:60-69.
18. Fukunaga K., Kohli P., Bonnans C., Fredenburgh L.E., Levy B.D. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J. Immunol. 2005, 174:5033-5039.
19. Ghabili K., Agutter P.S., Ghanei M., Ansarin K., Panahi Y., Shoja M.M. Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Crit. Rev. Toxicol. 2011, 41:384-403.
20. Ghanei M., Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal. Toxicol. 2007, 19:451-456.
21. Ghanei M., Harandi A.A. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal. Toxicol. 2011, 23:363-371.
22. Ghanei M., Adibi I., Farhat F., Aslani J. Late respiratory effects of sulfur mustard: how is the early symptoms severity involved?. Chron. Respir. Dis. 2008, 5:95-100.
23. Ghazanfari T., Yaraee R., Kariminia A., Ebtekar M., Faghihzadeh S., Vaez-Mahdavi M.R., Rezaei A., Vojgani M., Soroush M.R., Kermani-Jalilvand A., Mohammadi P., Foroutan A., Hassan Z.M. Alterations in the serum levels of chemokines 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int. Immunopharmacol. 2009, 9:1471-1476.
24. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
25. Heymann W.R. Threats of biological and chemical warfare on civilian populations. J. Am. Acad. Dermatol. 2004, 51:452-453.
26. Korkmaz A., Yaren H., Topal T., Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch. Toxicol. 2006, 80:662-670.
27. Laskin J.D., Heck D.E., Laskin D.L. Nitric oxide pathways in toxic responses. General and Applied Toxicology 2010, 425-438. Wiley-Blackwell, UK. B. Ballantyne, T. Marrs, T. Syversen (Eds.).
28. Laskin D.L., Sunil V.R., Gardner C.R., Laskin J.D. Macrophages and tissue injury: agents of defense or destruction?. Annu. Rev. Pharmacol. Toxicol. 2011, 51:267-288.
29. Leme A.S., Berndt A., Williams L.K., Tsaih S.W., Szatkiewicz J.P., Verdugo R., Paigen B., Shapiro S.D. A survey of airway responsiveness in 36 inbred mouse strains facilitates gene mapping studies and identification of quantitative trait loci. Mol. Genet. Genomics 2010, 283:317-326.
30. Malaviya R., Sunil V.R., Cervelli J., Anderson D.R., Holmes W.W., Conti M.L., Gordon R.E., Laskin J.D., Laskin D.L. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol. Appl. Pharmacol. 2010, 248:89-99.
31. Marshall E. Iraq's chemical warfare: case proved: A U.N. team found mustard and nerve gas bombs on the battlefield; now the challenge is to prevent the war from spreading. Science 1984, 224:130-132.
32. Menzies F.M., Henriquez F.L., Alexander J., Roberts C.W. Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation. Clin. Exp. Immunol. 2010, 160:369-379.
33. Meyer K.C., Ershler W., Rosenthal N.S., Lu X.G., Peterson K. Immune dysregulation in the aging human lung. Am. J. Respir. Crit. Care Med. 1996, 153:1072-1079.
34. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
35. Naghii M.R. Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil. Med. 2002, 167:573-575.
36. Playford R.J., Belo A., Poulsom R., Fitzgerald A.J., Harris K., Pawluczyk I., Ryon J., Darby T., Nilsen-Hamilton M., Ghosh S., Marchbank T. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 2006, 131:809-817.
37. Ricciardolo F.L., Di Stefano A., Sabatini F., Folkerts G. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol. 2006, 533:240-252.
38. 2 toxicity. Arch. Med. Res. 2008, 39:560-566.
39. Roudkenar M.H., Halabian R., Roushandeh A.M., Nourani M.R., Masroori N., Ebrahimi M., Nikogoftar M., Rouhbakhsh M., Bahmani P., Najafabadi A.J., Shokrgozar M.A. Lipocalin 2 regulation by thermal stresses: protective role of Lcn2/NGAL against cold and heat stresses. Exp. Cell Res. 2009, 315:3140-3151.
40. Saika S. Yin and yang in cytokine regulation of corneal wound healing: roles of TNF-alpha. Cornea 2007, 26:S70-S74.
41. Sugiura H., Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide 2011, 25:138-144.
42. Sunil V.R., Patel K.J., Nilsen-Hamilton M., Heck D.E., Laskin J.D., Laskin D.L. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp. Mol. Pathol. 2007, 83:177-187.
43. Sunil V.R., Patel-Vayas K., Shen J., Gow A.J., Laskin J.D., Laskin D.L. Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Toxicol. Appl. Pharmacol. 2011, 250:245-255.
44. Sunil V.R., Patel K.J., Shen J., Reimer D., Gow A.J., Laskin J.D., Laskin D.L. Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard. Toxicol. Appl. Pharmacol. 2011, 250:10-18.
45. Tankersley C.G., Shank J.A., Flanders S.E., Soutiere S.E., Rabold R., Mitzner W., Wagner E.M. Changes in lung permeability and lung mechanics accompany homeostatic instability in senescent mice. J. Appl. Physiol. 2003, 95:1681-1687.
46. Ucar M., Korkmaz A., Reiter R.J., Yaren H., Oter S., Kurt B., Topal T. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol. Lett. 2007, 173:124-131.
47. Weinberger B., Laskin J.D., Sunil V.R., Sinko P.J., Heck D.E., Laskin D.L. Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity. Pulm. Pharmacol. Ther. 2011, 24:92-99.
48. Wormser U., Langenbach R., Peddada S., Sintov A., Brodsky B., Nyska A. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. Toxicol. Appl. Pharmacol. 2004, 200:40-47.
49. Wu H., Santoni-Rugiu E., Ralfkiaer E., Porse B.T., Moser C., Hoiby N., Borregaard N., Cowland J.B. Lipocalin 2 is protective against E. coli pneumonia. Respir. Res. 2010, 11:96.
50. Yaren H., Mollaoglu H., Kurt B., Korkmaz A., Oter S., Topal T., Karayilanoglu T. Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res. Vet. Sci. 2007, 83:116-122.
51. Zhang L., Wang M., Kang X., Boontheung P., Li N., Nel A.E., Loo J.A. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J. Proteome Res. 2009, 8:1631-1638.